Terry Hurst

569 total citations
18 papers, 477 citations indexed

About

Terry Hurst is a scholar working on Reproductive Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Terry Hurst has authored 18 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Terry Hurst's work include Ovarian cancer diagnosis and treatment (9 papers), Cancer-related Molecular Pathways (4 papers) and Cancer Genomics and Diagnostics (3 papers). Terry Hurst is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Cancer-related Molecular Pathways (4 papers) and Cancer Genomics and Diagnostics (3 papers). Terry Hurst collaborates with scholars based in Australia, United States and United Kingdom. Terry Hurst's co-authors include Bruce G. Ward, Georgia Chenevix‐Trench, Michael A. McGuckin, S. K. Khoo, Michael D. Walsh, Margaret C. Cummings, Peter G. Parsons, Peter J. Wilson, Sarah J. Morland and K Wright and has published in prestigious journals such as Journal of the American Academy of Child & Adolescent Psychiatry, International Journal of Cancer and Gynecologic Oncology.

In The Last Decade

Terry Hurst

17 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Terry Hurst Australia	11	276	202	157	76	63	18	477
Eva Glud Denmark	13	196 0.7×	272 1.3×	244 1.6×	36 0.5×	100 1.6×	15	523
Yinhua Yu China	8	284 1.0×	84 0.4×	176 1.1×	27 0.4×	108 1.7×	10	465
Jun Naniwa Japan	13	223 0.8×	158 0.8×	114 0.7×	79 1.0×	53 0.8×	19	399
Jin Yun Chen United States	5	218 0.8×	275 1.4×	124 0.8×	32 0.4×	111 1.8×	7	512
Shamima Yeasmin Japan	10	289 1.0×	94 0.5×	115 0.7×	39 0.5×	123 2.0×	19	442
Huaizeng Chen China	16	514 1.9×	124 0.6×	280 1.8×	75 1.0×	165 2.6×	44	788
Angela Ziebarth United States	7	345 1.3×	94 0.5×	254 1.6×	46 0.6×	125 2.0×	11	516
I Schönborn Germany	6	223 0.8×	102 0.5×	176 1.1×	54 0.7×	87 1.4×	14	373
Santiago Demajo Spain	9	281 1.0×	65 0.3×	99 0.6×	54 0.7×	60 1.0×	13	450

Countries citing papers authored by Terry Hurst

Since Specialization

Citations

This map shows the geographic impact of Terry Hurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Hurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Hurst more than expected).

Fields of papers citing papers by Terry Hurst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry Hurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Hurst. The network helps show where Terry Hurst may publish in the future.

Co-authorship network of co-authors of Terry Hurst

This figure shows the co-authorship network connecting the top 25 collaborators of Terry Hurst. A scholar is included among the top collaborators of Terry Hurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry Hurst. Terry Hurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Palumbo, Joseph, et al.. (2021). LONGER-TERM TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY (BRIGHT [ZYN2-CL-030]). Journal of the American Academy of Child & Adolescent Psychiatry. 60(10). S258–S258. 1 indexed citations

2.

Heussler, Helen, et al.. (2020). [BRIGHT (ZYN2-CL-030)] TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY. Journal of the American Academy of Child & Adolescent Psychiatry. 59(10). S264–S265.

3.

Young, Amy, D.P. Chynoweth, & Terry Hurst. (2000). What feedstocks work best in high carbon compost mix. Biocycle. 41(9). 51–53. 2 indexed citations

4.

Spurdle, Amanda B., Xiaohong Chen, Nicholas G. Martin, et al.. (2000). CYP17 promotor polymorphism and ovarian cancer risk. International Journal of Cancer. 86(3). 436–439. 35 indexed citations

5.

Wright, K, Peter J. Wilson, Sarah J. Morland, et al.. (1999). ?-Catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. International Journal of Cancer. 82(5). 625–629. 111 indexed citations

6.

Hurst, Terry, et al.. (1998). No Evidence for Microsatellite Instability from Allelotype Analysis of Benign and Low Malignant Potential Ovarian Neoplasms. Gynecologic Oncology. 69(3). 210–213. 22 indexed citations

7.

Dong, Ying, Susan J. Berners‐Price, David R. Thorburn, et al.. (1997). Serine Protease Inhibition and Mitochondrial Dysfunction Associated with Cisplatin Resistance in Human Tumour Cell Lines: Targets for Therapy. Griffith Research Online (Griffith University, Queensland, Australia). 37 indexed citations

8.

Dong, Ying, Michael D. Walsh, Michael A. McGuckin, et al.. (1997). Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis. International Journal of Cancer. 74(1). 57–63. 2 indexed citations

9.

Dong, Ying, Michael D. Walsh, Michael A. McGuckin, et al.. (1997). Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer. International Journal of Cancer. 74(4). 407–415. 68 indexed citations

10.

Chenevix‐Trench, Georgia, Terry Hurst, David Purdie, et al.. (1997). Analysis of loss of heterozygosity andKRAS2 mutations in ovarian neoplasms: Clinicopathological correlations. Genes Chromosomes and Cancer. 18(2). 75–83. 44 indexed citations

11.

Liu, Jim, et al.. (1997). Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours. International Journal of Cancer. 70(5). 508–511. 1 indexed citations

12.

Dong, Ying, Michael D. Walsh, Michael A. McGuckin, et al.. (1997). Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer. International Journal of Cancer. 74(4). 407–415. 3 indexed citations

13.

Liu, Jim, et al.. (1997). Rare mutations and no hypermethylation at theCDKN2A locus in epithelial ovarian tumours. International Journal of Cancer. 70(5). 508–511. 36 indexed citations

14.

Leary, Jennifer, et al.. (1995). Increased expression of the nme1 gene is associated with metastasis in epithelial ovarian cancer. International Journal of Cancer. 64(3). 189–195. 23 indexed citations

15.

McGuckin, Michael A., et al.. (1994). Effect Of Interferon‐γ and TNF‐α on MUCl MUCIN Expression in Ovarian Carcinoma Cell Lines. Disease Markers. 12(1). 43–50. 30 indexed citations

16.

McGuckin, Michael A., et al.. (1994). Effect of interferon ? and tumour necrosis factor ? on sensitivity to cisplatin in ovarian carcinoma cell lines. Cancer Immunology Immunotherapy. 39(2). 100–104. 8 indexed citations

17.

McGuckin, Michael A., Guy T. Layton, Mark Bailey, et al.. (1990). Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma—Comparison with CA125. Gynecologic Oncology. 37(2). 165–171. 37 indexed citations

18.

Khoo, S. K., Terry Hurst, Maurice J. Webb, et al.. (1987). Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomy. European Journal of Cancer and Clinical Oncology. 23(6). 765–771. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact